For the liver, the main drugs are hepatoprotective drugs and drugs for the treatment of viral hepatitis in patients. The main hepatoprotective drugs are reduced glutathione, atomorelin, thiopronine, and related drugs such as hepatocyte stimulating hormone and diammonium glycyrrhizate, all of which act on the patient’s liver cells and facilitate the growth of liver cells and the recovery of liver function. For patients with elevated glutathione and glutamic oxalacetic aminotransferase, if the elevated values are not high and viral hepatitis is excluded, patients need to actively take some, such as bifenthrin drops and dicyclomine tablets, in addition to changing their daily habits, to actively reduce aminotransferase therapy or hepatoprotective therapy. In addition, for patients with viral hepatitis, viral drugs are mainly injectable interferon, oral lamivudine, entecavir, adefovir and other drugs, these drugs are traditional antiviral oral drugs, but these drugs have been taken, it is recommended that patients do not stop the drug, because after stopping the drug, it will cause the rebound of the patient’s viral replication, and further cause the patient’s liver insufficiency, or liver failure may.